Suppliers / Cad Middle East Pharmaceutical Industries

Cad Middle East Pharmaceutical Industries

Saudi Arabia 81 employees Updated 9 July 2026

Cad Middle East Pharmaceutical Industries is an API manufacturer based in Saudi Arabia.

0
active US DMFs
0
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Riyadh, Saudi Arabia Not on file

What they file, and where

Molecule Regulators Docs
Azithromycin SFDA (Saudi Arabia) 1
Canagliflozin SFDA (Saudi Arabia) 1
Clarithromycin SFDA (Saudi Arabia) 1
Clopidogrel SFDA (Saudi Arabia) 1
Daclatasvir Dihydrochloride SFDA (Saudi Arabia) 1
Gliclazide SFDA (Saudi Arabia) 1
Glimepiride SFDA (Saudi Arabia) 1
Levofloxacin SFDA (Saudi Arabia) 1
Pantoprazole SFDA (Saudi Arabia) 1
Paroxetine SFDA (Saudi Arabia) 1
Show all 17 molecules on file
Pregabalin SFDA (Saudi Arabia) 1
Pseudoephedrine SFDA (Saudi Arabia) 1
Quetiapine SFDA (Saudi Arabia) 1
Sofosbuvir SFDA (Saudi Arabia) 1
Tadalafil SFDA (Saudi Arabia) 1
Venlafaxine SFDA (Saudi Arabia) 1
Vildagliptin SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Show 2 more molecule pages

Comparing suppliers?

Choose your molecules and target markets. Cad Middle East Pharmaceutical Industries comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability